Metformin Hydrochloride Prolonged Release and Glimepiride

PRODUCT NAME: Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP (Glifab-M1)

Dosage Form: Tablets       

Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP (Glifab-M1) is a combination medicine prescribed to help manage blood glucose levels in adults with type 2 diabetes. Metformin Hydrochloride Prolonged Release helps reduce glucose production in the liver and improves the body’s response to insulin. Its prolonged-release formulation allows the medicine to be released gradually.

Glimepiride helps regulate blood glucose by encouraging the pancreas to produce and release insulin.The combination may be recommended when a healthcare professional considers both ingredients suitable for the patient. For effective management, take the medicine as prescribed, follow dietary advice, and monitor blood glucose regularly. Medical supervision is essential during treatment.

Category: Brand:

Description

MORE DETAILS ABOUT PRODUCT

Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP (Glifab-M1)

  • Primary Use: Glifab-M1 Tablets are prescribed to help control blood glucose levels in adults with type 2 diabetes when recommended by a healthcare professional.

  • Metformin Hydrochloride Prolonged Release: Helps reduce glucose production in the liver and improves the body’s response to insulin, supporting blood sugar management.

  • Glimepiride: Encourages the pancreas to release insulin, helping the body regulate blood glucose levels.

  • Combination Therapy: Brings together two active ingredients that work in different ways to help manage type 2 diabetes when a single medicine is not sufficient.

  • Dosage and Administration: Take Glifab-M1 Tablets exactly as prescribed. Follow your doctor’s instructions about meals and dosage, and monitor blood glucose regularly. Glimepiride may cause low blood sugar, so do not skip meals without medical advice.

Indications

Key Benefits of Glifab-M1 Tablets

  • Blood Glucose Management: Helps maintain blood sugar levels within the target range when used as part of a prescribed diabetes treatment plan.

  • Reduced Glucose Production: Metformin Hydrochloride Prolonged Release helps limit the amount of glucose produced by the liver.

  • Improved Insulin Response: Metformin supports the body’s ability to use insulin more effectively.

  • Supports Insulin Release: Glimepiride stimulates insulin secretion from the pancreas, helping regulate blood glucose levels.

  • Dual-Ingredient Formulation: Combines two medicines that work through different mechanisms to support the management of type 2 diabetes.

  • Gradual Medicine Release: The prolonged-release form of metformin releases the ingredient over an extended period, as designed by the formulation.

  • Ongoing Diabetes Management: Glifab-M1 may help maintain better blood glucose control when combined with a balanced diet, regular physical activity, routine sugar monitoring, and guidance from a healthcare professional.